StealTHY CRISPR: Revealing Hidden Metastasis Regulators
Music:
Enjoy the music based on this article at the end of the episode.
License:
CC BY 4.0 International License (CC BY 4.0)
Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
Official website https://basebybase.com
On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/stealthy-crispr-revealing-hidden-metastasis-regulators
️ Episode:
204: StealTHY CRISPR: Revealing Hidden Metastasis Regulators
️ Season:
1
Article title:
Stealthy CRISPR: Revealing Hidden Metastasis Regulators
Journal:
Cell
DOI:
10.1016/j.cell.2025.10.007
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-11-20.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited transcript sections describing CRISPR immunogenicity in vivo, stealth platform design (immune stealth reporters, autologous reporters, Hit-and-Run Cas9), Harakiri selection, library diversity preservation, AMHR2 axis as metastasis driver, and clinical relevance via TCGA.
- transcript topics: CRISPR immunogenicity in vivo and iatrogenic clonal dropout; Stealth platform design: immune stealth reporters, autologous reporters, Hit-and-Run Cas9; Harakiri selection and ex vivo purification; Preservation of sgRNA library diversity in immunocompetent models; AMHR2 axis as metastasis driver; Dominant negative AMHR2 decoy receptor therapy
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- Stealth CRISPR platform uses immune stealth reporters, HiT-and-Run (Hit-and-Run) Cas9 delivery, and Harakiri selection to render CRISPR screens immunologically inert
- In immunocompetent models, stealth platform preserves clonal diversity and full sgRNA library integrity
- AMHR2 axis identified as a major driver of metastasis; knockout yields a 20-fold reduction in metastases
- Dominant negative AMHR2 decoy receptor suppresses tumor volume by >80% and essentially abolishes metastasis in humanized/PDX models
- Blocking AMHR2 signaling shifts tumor immune microenvironment: reduced Tregs, increased activated macrophages and cytotoxic T cells; Type I interferon genes and STAT1 pathway upreg
- Human relevance supported via TCGA data showing high AMH expression correlates with poor prognosis in breast cancer
QC result: Pass.
Fler avsnitt av Base by Base
Visa alla avsnitt av Base by BaseBase by Base med Gustavo Barra finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
